Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
CN Stock MarketDetailed Quotes
Maccura Biotechnology (300463)
- 10.39
- -0.13-1.24%
Market Closed Apr 24 15:00 CST
6.28BMarket Cap-53.56P/E (TTM)
10.54High10.39Low60.32KlotVolume10.50Open10.52Prev Close62.90MTurnover1.23%Turnover Ratio49.48P/E (Static)604.67MShares14.2052wk High0.99P/B5.11BFloat Cap10.3952wk Low12.62Limit Up491.80MShs Float63.74Historical High8.42Limit Down1.43%Range %9.00Historical Low0.10Dividend TTM10.43Avg Price28.78KlotAsk1.00%Div Yield TTM100Lot Size29.38KlotBid
Maccura Biotechnology (300463) Balance Sheet
All
YOY
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -18.70%674.79M | -30.76%659.87M | -5.75%772.11M | -19.68%671.45M | 7.83%829.96M | 11.50%952.97M | 1.66%819.18M | 42.33%835.96M | -7.09%769.66M | -33.53%854.67M |
| Transactional financial assets | -58.19%50.2M | -64.12%50.31M | ---- | -80.70%60.06M | -70.84%120.07M | -70.32%140.19M | -74.12%140.52M | -53.12%311.14M | -38.95%411.78M | 52.31%472.33M |
| Notes receivable and accounts receivable | -18.06%1.29B | -20.28%1.33B | -16.07%1.46B | -11.89%1.58B | -12.00%1.58B | -10.66%1.67B | -11.86%1.74B | -15.12%1.79B | -13.05%1.79B | -7.59%1.87B |
| -Notes receivable | -12.78%14.26M | -49.94%13.41M | -42.69%17.67M | -15.60%17.1M | -73.84%16.35M | -58.66%26.79M | 71.93%30.84M | -48.50%20.26M | 36.05%62.5M | 24.45%64.79M |
| -Accounts receivable | -18.12%1.28B | -19.79%1.32B | -15.59%1.44B | -11.85%1.56B | -9.77%1.56B | -8.94%1.65B | -12.63%1.71B | -14.48%1.77B | -14.17%1.73B | -8.43%1.81B |
| Other receivables (including interest and dividends) | -19.50%19.7M | -15.36%24.76M | -14.63%24.74M | -15.75%23.3M | -1.57%24.47M | 23.11%29.25M | 51.55%28.98M | 42.45%27.65M | 15.33%24.86M | 17.42%23.76M |
| -Other receivable | ---- | -15.36%24.76M | ---- | ---- | ---- | 23.11%29.25M | ---- | 42.45%27.65M | ---- | 17.42%23.76M |
| Advance payment | -26.78%111.56M | -44.00%106.59M | -32.20%160.28M | -19.13%156.64M | -34.67%152.37M | 22.33%190.35M | 44.28%236.4M | 33.01%193.69M | 32.43%233.23M | -2.88%155.6M |
| Inventories | -7.15%931.05M | 4.49%1.04B | -3.62%973.22M | -0.65%901.58M | -8.21%1B | -8.40%990.96M | -10.30%1.01B | -12.70%907.49M | 9.09%1.09B | 8.66%1.08B |
| Receivable financing | -78.29%3.7M | -29.04%16.4M | -55.21%15.21M | -77.26%9.12M | -59.24%17.03M | -39.19%23.11M | 87.97%33.97M | 76.30%40.09M | 159.54%41.79M | 133.14%38M |
| Other current assets | 85.69%327.89M | 117.29%327.73M | 144.88%279.33M | 110.59%237.2M | 65.32%176.58M | 53.58%150.82M | -5.04%114.07M | 6.01%112.64M | 8.30%106.81M | 12.66%98.21M |
| Total current assets | -12.55%3.41B | -14.35%3.55B | -10.61%3.68B | -13.80%3.64B | -12.80%3.9B | -9.71%4.15B | -13.56%4.12B | -10.12%4.22B | -8.31%4.47B | -6.22%4.6B |
| Non Current assets | ||||||||||
| Other equity investment | -4.65%123.12M | -11.00%123.08M | -12.82%121.47M | -0.63%138.89M | -1.53%129.13M | -1.43%138.29M | -1.34%139.34M | -7.46%139.77M | -12.29%131.14M | -16.88%140.3M |
| Other non-current financial assets | -6.43%23.73M | -25.15%23.72M | -24.72%24.09M | 6.32%35.04M | -7.69%25.36M | -5.72%31.69M | -6.50%32M | -19.18%32.96M | -31.21%27.47M | -36.21%33.61M |
| Investment real estate | -2.84%63.28M | -2.82%63.74M | -2.86%64.17M | -2.79%64.67M | -2.77%65.13M | -2.75%65.59M | -2.73%66.06M | -2.72%66.52M | -2.70%66.98M | -2.68%67.45M |
| Long-term equity investment | ---- | ---- | --2M | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Fixed assets | ---- | 2.00%2.29B | ---- | ---- | ---- | 12.43%2.24B | ---- | 10.49%2.19B | ---- | 3.81%1.99B |
| Constru in process | ---- | 35.98%1.24B | ---- | ---- | ---- | 41.87%911.3M | ---- | 41.76%714.48M | ---- | 161.20%642.33M |
| Intangible assets | 7.05%359.8M | 20.07%355.47M | 18.62%362.28M | 32.45%375.16M | 9.70%336.12M | 13.42%296.04M | 16.66%305.41M | 5.15%283.25M | 24.81%306.39M | 2.84%261M |
| Development expenditure | 29.47%160.31M | 5.43%155.03M | 11.74%140.06M | -15.32%116.48M | 12.31%123.82M | 6.83%147.05M | 4.28%125.34M | 30.87%137.54M | 3.51%110.25M | 57.29%137.65M |
| Goodwill | -64.84%51.04M | -64.84%51.04M | -64.84%51.04M | -64.84%51.04M | 0.00%145.15M | 0.00%145.15M | 0.00%145.15M | 0.00%145.15M | -0.87%145.15M | -0.87%145.15M |
| Long deferred expense | 91.64%6.55M | -53.03%1.9M | -37.03%2.94M | -35.79%3.12M | -40.78%3.42M | -39.70%4.04M | -52.94%4.66M | -41.58%4.86M | -49.61%5.77M | -40.54%6.7M |
| Deferred tax assets | -18.02%121.13M | -16.37%122.67M | -31.94%102.29M | -13.06%133.78M | -14.73%147.75M | -17.66%146.67M | -10.48%150.3M | -4.70%153.86M | 4.63%173.27M | 16.78%178.14M |
| Usufruct assets | -38.52%11.61M | -42.28%12.96M | -37.05%15.61M | -40.69%16.8M | -25.79%18.89M | -17.24%22.45M | -20.46%24.8M | -5.92%28.33M | -24.88%25.46M | -25.54%27.12M |
| Other non current assets | 348.27%16.44M | 494.31%21.8M | 291.16%14.35M | 201.10%11.04M | -75.73%3.67M | -36.19%3.67M | -36.19%3.67M | -39.62%3.67M | -21.91%15.11M | 58.29%5.75M |
| Total non current assets | 6.34%4.58B | 7.31%4.46B | 9.37%4.38B | 11.28%4.34B | 14.52%4.3B | 14.14%4.15B | 14.29%4B | 12.28%3.9B | 14.17%3.76B | 15.50%3.64B |
| Total assets | -2.64%7.99B | -3.52%8.01B | -0.77%8.06B | -1.76%7.98B | -0.33%8.21B | 0.83%8.3B | -1.77%8.12B | -0.60%8.12B | 0.75%8.23B | 2.28%8.24B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -4.48%325.48M | 30.94%331.72M | 90.44%377.57M | 76.36%255.1M | 16.58%340.74M | -15.56%253.33M | -15.21%198.26M | -41.69%144.65M | -20.45%292.29M | -21.76%300.02M |
| Notes payable and accounts payable | -7.44%245.58M | -4.19%262.18M | 7.53%311.15M | -13.42%316.75M | -36.54%265.33M | -25.65%273.65M | -28.07%289.35M | -3.95%365.85M | 11.74%418.12M | 11.65%368.07M |
| -Notes payable | -24.96%16.48M | -5.42%9.21M | 64.25%36.86M | 32.28%106.45M | -71.29%21.96M | 67.96%9.74M | 0.95%22.44M | 4,366.02%80.47M | 217.10%76.5M | --5.8M |
| -Accounts payable | -5.86%229.1M | -4.15%252.97M | 2.76%274.28M | -26.31%210.29M | -28.76%243.36M | -27.15%263.91M | -29.76%266.9M | -24.72%285.37M | -2.41%341.62M | 9.89%362.27M |
| Contract liabilities | -3.36%77.69M | 6.39%92.26M | -7.30%77.95M | -0.44%72.04M | 22.43%80.4M | 3.66%86.73M | 3.00%84.09M | -2.76%72.36M | -1.17%65.67M | 22.65%83.66M |
| Salaries payable | -28.72%33.09M | -1.14%48.78M | 15.15%56.55M | -14.62%99.65M | 6.18%46.42M | 17.96%49.35M | 13.13%49.11M | -10.63%116.72M | 3.23%43.72M | -2.93%41.84M |
| Taxs payable | -34.36%21.11M | -2.56%24.51M | 2.47%37.68M | 7.13%43.93M | -42.81%32.16M | -40.92%25.15M | -50.86%36.77M | -35.42%41M | 10.99%56.23M | -16.91%42.57M |
| Other payable (including interest and dividends) | -48.83%103.82M | -14.10%118M | 535.58%145.48M | 640.88%185.19M | 859.23%202.89M | 627.08%137.37M | -10.98%22.89M | 8.68%25M | -65.72%21.15M | -79.84%18.89M |
| -Dividend payable | -63.75%52.64M | -44.03%52.64M | --93.44M | --122.18M | --145.2M | --94.06M | ---- | ---- | ---- | ---- |
| -Other payable | ---- | 50.92%65.36M | ---- | ---- | ---- | 129.23%43.31M | ---- | 8.68%25M | ---- | -79.84%18.89M |
| Non current liabilities due within one year | -37.90%162.13M | -69.23%125.07M | -42.74%224.4M | -38.77%211.28M | -13.16%261.1M | 103.23%406.45M | 157.21%391.92M | 126.55%345.04M | 91.99%300.65M | -2.07%200M |
| Other current liabilities | 20.07%11.78M | 34.33%14.46M | 28.20%12.93M | 20.36%12.03M | 13.53%9.81M | -0.42%10.76M | -2.62%10.09M | -5.53%9.99M | -10.83%8.64M | 8.24%10.81M |
| Total current liabilities | -20.84%980.67M | -18.17%1.02B | 14.90%1.24B | 6.72%1.2B | 2.68%1.24B | 16.60%1.24B | 5.67%1.08B | 3.44%1.12B | 6.85%1.21B | -9.94%1.07B |
| Current liabilities | ||||||||||
| Long term loan | 266.63%522.97M | 243.44%496.76M | 117.94%244.1M | 13.30%184.12M | -29.56%142.64M | -65.85%144.64M | -66.28%112M | -43.14%162.5M | -39.06%202.5M | 26.83%423.5M |
| Estimate liabilities | 10.89%3.97M | 103.74%7.62M | 102.15%7.74M | 107.38%7.94M | --3.58M | --3.74M | --3.83M | --3.83M | ---- | ---- |
| Deferred tax liabilities | -55.87%74.08M | -50.36%87.78M | -38.87%107.28M | -25.17%134M | -20.13%167.87M | -19.44%176.85M | -22.54%175.48M | -19.96%179.07M | -10.32%210.18M | -5.30%219.52M |
| Long term deferred income | -8.11%24.13M | -4.47%24.13M | -16.21%24.13M | -17.26%23.83M | -16.19%26.26M | -19.25%25.26M | -8.49%28.8M | -7.31%28.8M | 2.95%31.33M | 4.15%31.28M |
| Lease liabilities | -54.66%3.78M | -56.67%5.25M | -22.53%7.3M | -47.66%6.79M | -42.99%8.35M | -22.09%12.11M | -45.83%9.43M | -13.71%12.98M | -19.72%14.64M | -19.22%15.54M |
| Total non current liabilities | 80.37%628.93M | 71.41%621.55M | 18.51%390.55M | -7.88%356.69M | -23.97%348.7M | -47.44%362.6M | -45.76%329.54M | -30.32%387.18M | -25.46%458.66M | 12.17%689.84M |
| Total liabilities | 1.39%1.61B | 2.06%1.64B | 15.74%1.63B | 2.98%1.55B | -4.66%1.59B | -8.56%1.61B | -13.47%1.41B | -8.00%1.51B | -4.55%1.67B | -2.38%1.76B |
| Shareholders equity | ||||||||||
| Paid-in capital | -1.27%604.67M | 0.00%612.47M | 0.00%612.47M | 0.00%612.47M | 0.00%612.47M | 0.00%612.47M | 0.00%612.47M | 0.00%612.47M | 0.00%612.47M | 0.00%612.47M |
| Capital reserve funds | -12.29%1.57B | -0.11%1.78B | 0.18%1.78B | 0.13%1.78B | 0.36%1.79B | 0.03%1.78B | 0.00%1.78B | 0.00%1.78B | 0.08%1.78B | 0.08%1.78B |
| Surplus reserve funds | -0.70%304.1M | -0.71%304.07M | -0.60%304.4M | 0.00%306.23M | 0.00%306.23M | 0.00%306.23M | 0.00%306.23M | 0.00%306.23M | 10.06%306.23M | 10.06%306.23M |
| Retained profit | -4.49%3.85B | -2.64%3.84B | -1.61%3.9B | 0.85%3.87B | 6.09%4.03B | 6.63%3.95B | 2.69%3.96B | 2.68%3.84B | 3.69%3.8B | 6.82%3.7B |
| Less:Treasury stock | ---- | 14.08%220.24M | 14.09%220.24M | 29.41%220.24M | 21.07%206.04M | 13.44%193.06M | 13.43%193.04M | 0.00%170.18M | 0.00%170.18M | 0.00%170.18M |
| Other composite income | -78.58%1.25M | -91.05%1.22M | -91.58%1.22M | -4.78%14.18M | -8.37%5.85M | -3.74%13.64M | -2.88%14.53M | -36.06%14.89M | -70.98%6.39M | -63.09%14.17M |
| Shareholders equity without minority interests | -3.20%6.33B | -2.29%6.32B | -1.59%6.38B | -0.25%6.37B | 3.18%6.54B | 3.56%6.47B | 1.26%6.48B | 1.46%6.38B | 2.41%6.33B | 4.02%6.25B |
| Minority interests | -35.94%53.27M | -78.08%49.85M | -78.81%48.82M | -75.91%54.61M | -64.43%83.16M | -1.90%227.41M | -2.84%230.44M | -4.07%226.64M | -3.65%233.83M | -6.21%231.81M |
| Total shareholder equity | -3.61%6.38B | -4.86%6.37B | -4.24%6.43B | -2.84%6.42B | 0.77%6.62B | 3.37%6.7B | 1.11%6.71B | 1.26%6.61B | 2.18%6.57B | 3.62%6.48B |
| Total liabilityies and equity | -2.64%7.99B | -3.52%8.01B | -0.77%8.06B | -1.76%7.98B | -0.33%8.21B | 0.83%8.3B | -1.77%8.12B | -0.60%8.12B | 0.75%8.23B | 2.28%8.24B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm